Have you ever eaten a very hot chili pepper? If so, you have felt the TRPV1 receptor at work. It sits on the surface of nerve cells that sense pain. Many scientists call it the capsaicin receptor. Capsaicin is the chemical that makes chili peppers taste burning hot. Some pain creams contain it for this reason.
A new study from the UC Davis School of Medicine shows that this receptor is more complex than experts believed. The results were published in the journal PNAS. In the future, they may help scientists create better pain medicines.
Why TRPV1 Is Important
TRPV1 does more than respond to spicy food. It also detects heat, damage to body tissue, and swelling or inflammation. The receptor sends a pain message to the brain when the body is harmed.
Because of this role, researchers have long viewed TRPV1 as a viable target for new drugs. A medicine that blocks it would not need to use the body’s opioid system. This approach is useful because opioid painkillers can lead to addiction.
However, there is a major problem. TRPV1 also helps the body manage its temperature. In the past, drugs that blocked the receptor often caused dangerous changes in body temperature. These side effects have slowed progress for many years.
An Old Belief Is Challenged
TRPV1 works like a tiny gate in the cell’s outer layer. When the gate opens, charged particles flow through and create an electrical signal. For a long time, scientists believed the gate opened in just one way. They assumed it looked the same whether it was triggered by heat, acid, or a chemical.
The new study suggests this is not true. According to the team, different triggers seem to hold the gate open in different ways. Each way has its own features.
“Our findings show that the receptor is more sophisticated than that,” said Bo Hyun Lee, the study’s first author and a former member of the research group.
How the Team Tested This
The researchers measured the tiny electrical currents moving through single TRPV1 channels. They triggered the channels in five different ways:
- Capsaicin, the hot compound in chili peppers
- Resiniferatoxin, an extremely hot compound from a plant
- Protons, which make conditions acidic, as happens during injury and swelling
- 2-APB, a chemical often used to change how ion channels behave
- Heat
Each trigger produced a different level of current. This hinted that the channel was not opening in the same way each time.
To verify this idea, the team used more tools. First, they measured how quickly charged particles pass through the channel. These tests showed that the shape of the channel’s central pore changed depending on the trigger.
Next, they used a glowing-marker method in living cells. This let them watch different parts of the protein move as the channel responded to each stimulus.
Finally, they used computer models to picture how the receptor’s structure shifted in each case.
All three approaches pointed to the same answer. TRPV1 has several different open forms.
Senior author Jie Zheng said the agreement between the methods gave the team confidence. He explained that the results are real functional states and not mistakes in the experiments.
A Surprising Slowdown
The team found something else that nobody expected. When two triggers were applied at the same time, the channel opened more slowly. Many people would guess that two triggers together would speed things up.
This suggests that different ways of activating the receptor can get in each other’s way. It adds another layer to how the body handles pain signals.
What This Could Mean for Patients
The findings may point toward smarter drugs. If the receptor has different open states, you can target only the ones linked to pain. Other states, such as those involved in sensing normal warmth, could be left alone.
That could mean pain relief without the dangerous temperature problems seen in earlier attempts. Vladimir Yarov-Yarovoy, a co-author of the study, explained what the findings could mean for future treatments.
He said that TRPV1 may enter different states depending on how it is activated. If so, scientists might one day build drugs that target only the activity linked to pain. Those drugs would leave the body’s other important functions alone.
The research also helps scientists understand how proteins behave when they meet unusual triggers. That knowledge is useful well beyond pain research.
Still a Long Road Ahead
It is important to be realistic. This study does not give us a new drug yet. It offers a new way of conceptualizing TRPV1 and a possible roadmap for future work. Much more research is needed before these ideas can become real treatments.
Still, the results are encouraging. They show that even a well-studied receptor can hold surprises. Understanding those surprises may lead to safer, more precise pain medicines in the years to come. The study also involved Shisheng Li, Simon Vu, and Zhihao Yao from UC Davis, and Yuhua Tian from UC Davis and Qingdao University.
